ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld


GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market


Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today’s Transactions:
Allergan Pays $958M for Map Pharmaceuticals

Map Pharmaceuticals is developing migraine treatment Levadex

Allergan Inc. (NYSE: AGN) is buying Map Pharmaceuticals Inc. (Nasdaq: MAPP) for $958 million.

Mountain View, Calif.-based Map is a biopharmaceutical company focused on developing new neurology medications, including Levadex, an orally inhaled drug that could potentially treat adult migraines. Levadex is currently under review with the U.S. Food and Drug Administration.

Allergan, headquartered in Irvine, Calif., has gotten regulatory approval in 56 countries to use Botox to treat chronic migraines, and expects to continue developing Levadex as a complementary migraine treatment option.

The buyer is a healthcare company that focuses on the eye care, neurosciences, medical aesthetics, dermatology, obesity and other areas. The deal was announced late Jan. 22.

In November Allergan agreed to buy SkinMedica Inc., a company that makes topical skin-care products, for $350 million.


For more information on related topics, visit the following: